Dror Bashan
2019
In 2019, Dror Bashan earned a total compensation of $391.6K as President and Chief Executive Officer at Protalix BioTherapeutics.
Compensation breakdown
| Option Awards | $161,792 |
|---|---|
| Salary | $174,725 |
| Other | $55,082 |
| Total | $391,599 |
Bashan received $174.7K in salary, accounting for 45% of the total pay in 2019.
Bashan also received $161.8K in option awards and $55.1K in other compensation.
Rankings
In 2019, Dror Bashan's compensation ranked 12,397th out of 13,971 executives tracked by ExecPay. In other words, Bashan earned more than 11.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,397 out of 13,971 | 11th |
Division Manufacturing | 5,016 out of 5,701 | 12th |
Major group Chemicals And Allied Products | 1,975 out of 2,200 | 10th |
Industry group Drugs | 1,699 out of 1,886 | 10th |
Industry Biological Products, Except Diagnostic Substances | 366 out of 389 | 6th |
Source: SEC filing on April 15, 2020.
Bashan's colleagues
We found six more compensation records of executives who worked with Dror Bashan at Protalix BioTherapeutics in 2019.
2019
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2019
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2019
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2019
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
2019
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2019
Eyal Rubin
Protalix BioTherapeutics
Chief Financial Officer
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020